Pharmacy Joe

APRIL 3, 2024

In this episode, I’ll discuss how to judge whether a journal is reputable. Episode 910: How to judge whether a journal is reputable? Subscribe on iTunes , Android , or Stitcher There are dozens of well-established journals that when we read an article in them, the thought never comes to mind “Is this journal reputable?”

Inpatient 40

Inpatient 40

Safe Biologics

FEBRUARY 1, 2024

The paper’s authors include three former government officials who worked on the development and implementation of Medicare Part D, the prescription drug benefit being modified by the IRA’s new price-setting provisions; as well as a prominent patient advocacy leader: Michael S Reilly, Esq; Executive Director, ASBM Thomas R Barker, Esq; Former (..)

Drug Pricing 100

Drug Pricing Biosimilars 100

Safe Biologics

MAY 9, 2023

On May 9th, GaBI Journal published a whitepaper titled “Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars”, based on the recent survey of 41 Canadian ophthalmologists by ASBM and the International Federation on Ageing (IFA).

Biosimilars 100

Biosimilars 100

Safe Biologics

MAY 9, 2023

On May 9th, GaBI Journal published a whitepaper titled “Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars”, based on the recent survey of 41 Canadian ophthalmologists by ASBM and the International Federation on Ageing (IFA).

Biosimilars 100

Biosimilars 100

Pharmacy Joe

JANUARY 24, 2024

In this episode, I’ll discuss how to guarantee you pick a great article for the journal club. Episode 890: How to Succeed at Journal Club Without Really Trying Subscribe on iTunes , Android , or Stitcher There are two important criteria that are essential to fulfill when presenting an article to a journal club: 1.

Inpatient 52

Inpatient Hospitals 52

Safe Biologics

MAY 10, 2023

On May 9th, GaBI Journal published a whitepaper titled “Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars”, based on the recent survey of 41 Canadian ophthalmologists by ASBM and the International Federation on Ageing (IFA).

Biosimilars 100

Biosimilars 100

Safe Biologics

MAY 10, 2023

On May 9th, GaBI Journal published a whitepaper titled “Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars”, based on the recent survey of 41 Canadian ophthalmologists by ASBM and the International Federation on Ageing (IFA).

Biosimilars 100

Biosimilars 100

Pharmafile

DECEMBER 5, 2023

A group of medical professionals and politicians have published an open letter in the British Medical Journal which calls on the Government to commit to a reversal in the rate of prescribing of antidepressants.

59

59

Safe Biologics

DECEMBER 20, 2022

The paper was published in GaBI Journal, Volume 11, Year 2022, Issue 3. In addition, most physicians favored a scenario where multiple products, including innovator and biosimilars are reimbursed, and biosimilars may be encouraged for new patients with no automatic substitution permitted. Read the full paper online here.

Biosimilars 100

Biosimilars 100

STAT

MAY 6, 2024

WASHINGTON – Two New York University professors collaborated directly with executives of the vaping company Juul without disclosing those relationships to academic journals or Congress, a STAT investigation reveals. Continue to STAT+ to read the full story…

Documentation 363

Documentation 363

Outsourcing Pharma

NOVEMBER 22, 2023

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

70

70

STAT

DECEMBER 11, 2023

The New England Journal of Medicine on Monday will launch NEJM AI , a monthly, online-only publication that will focus on evaluating applications of artificial intelligence in clinical medicine. The journal will also publish review articles, policy perspectives, and educational materials for physicians and computer scientists.

333

333

STAT

MAY 14, 2024

But a new paper published Monday in the Journal of Neurotrauma suggests waiting a little longer — and gathering more data — may be beneficial. With the support of critical care physicians, most decisions on whether to end life support are made within 72 hours of hospitalization. Read the rest…

Hospitals 266

Hospitals 266

Pharmacy Joe

AUGUST 28, 2022

In this episode, I’ll discuss how to become a peer reviewer for a medical journal. Additionally, being a peer reviewer helps uphold the scientific process, supports your favorite journal, and helps establish professional relationships. Reach out to journals 3. Don’t associate with predatory journals.

Hospitals 52

Hospitals Inpatient 52

STAT

MAY 6, 2024

The study, a preprint that hasn’t yet been through peer review by a scientific journal, found that tissue from the mammary gland contains abundant receptors of the kind to which avian flu viruses like H5N1 can attach. dairy cattle — and also is sparking debate about the implications of the cow outbreak for human disease.

339

339

Pharmafile

MARCH 31, 2023

ALM) , a global biopharmaceutical company focused on medical dermatology, announced today the publication of Week 16 and Week 52 results of ADvocate1 and ADvocate2 by the New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD), respectively. read more

52

52

World Pharma News

JUNE 6, 2023

AbbVie (NYSE: ABBV) announced the New England Journal of Medicine (NEJM) published results from the pivotal Phase 3 clinical trials - U-EXCEL, U-EXCEED and U-ENDURE - evaluating upadacitinib (RINVOQ®) in adult patients with moderately to severely active Crohn's disease who have had an inadequate response, lost response or were intolerant to conventional (..)

90

90

The Digital Apothecary

DECEMBER 12, 2015

Why I Love Open-Access Journals The open-access movement has always struck a chord with me. Traditional journal models aren't going to go away anytime soon (I believe at least), but many are starting to adopt to an open access model or make such options available. Thats great. Predatory Publishing?

130

130

Pharma Mirror

SEPTEMBER 15, 2020

The Royal Society of Chemistry has launched its new Text and Data Mining (TDM) solution, making its full collection of research journals available to companies for AI and machine learning applications.

97

97

STAT

MARCH 17, 2023

LOUIS — It’s been eight months since Kirsten Bibbins-Domingo, a general internist, cardiovascular researcher, and epidemiologist became the 17th editor in chief of the Journal of the American Medical Association and its network of journals. Bibbins-Domingo also spoke about what lies ahead for JAMA.

329

329

pharmaphorum

AUGUST 14, 2020

The best timing for screening is a hotly-debated topic, and the British Medical Journal ran an article challenging the Lancet Oncology findings on the day of publication, citing experts who dismissed the findings as “misleading rhetoric.”. The post UK medical journals spar over breast cancer screening study appeared first on.

92

92

STAT

APRIL 3, 2024

In a Phase 2 trial, patients with early Parkinson’s disease taking an older GLP-1 diabetes drug called lixisenatide experienced no worsening of motor symptoms over a year, in contrast to patients on placebo who did, according to the study, published Wednesday in the New England Journal of Medicine. Read the rest…

Diabetes 363

Diabetes Drug Development 363

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI.

Biosimilars 100

Biosimilars 100

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI.

Biosimilars 100

Biosimilars 100

STAT

APRIL 24, 2024

The New England Journal of Medicine recently published a pivotal paper that found a blood test can detect the early stages of colorectal cancer, which is one of a handful of cancers that is increasing every year in Americans younger than age 50.

343

343

Pharmacy Joe

JANUARY 2, 2022

In this episode, I’ll discuss how to judge whether a journal is reputable. Episode 675: How to judge whether a journal is reputable? There are dozens of well-established journals that when we read an article in them, the thought never comes to mind “Is this journal reputable? Is the journal indexed?

Inpatient 40

Inpatient 40

STAT

MAY 13, 2024

” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “ It’s The Prices, Stupid.” ” Continue to STAT+ to read the full story…

Hospitals 312

Hospitals 312

Pharmacy Joe

AUGUST 28, 2022

In this episode, I’ll discuss how to become a peer reviewer for a medical journal. Additionally, being a peer reviewer helps uphold the scientific process, supports your favorite journal, and helps establish professional relationships. Reach out to journals 3. Don’t associate with predatory journals.

Hospitals 40

Hospitals Inpatient 40

STAT

JANUARY 10, 2023

Journals use corrections and retractions to resolve those mistakes. But one particularly high-profile case is now drawing fresh attention to the problems with journals’ process for addressing concerns about research integrity. Mistakes happen — in life, in the lab, and, inevitably, in research papers, too.

336

336

STAT

APRIL 29, 2024

The results were published two years ago in the New England Journal of Medicine and the total cost for the undertaking was $36 million, according to Doctors Without Borders. Continue to STAT+ to read the full story…

328

328

STAT

FEBRUARY 8, 2024

A medical journal has retracted two studies claiming to show the harms of the abortion pill mifepristone, citing conflicts of interest by the authors and flaws in their research. The  U.S.

357

357

STAT

FEBRUARY 1, 2024

A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 1.5 — and the JN.1 1 subvariant, which emerged after the vaccine was made.

Vaccines 364

Vaccines 364

STAT

JANUARY 25, 2024

But the study, published on Monday in the Journal of the National Cancer Institute , is the first to monitor a national cohort of women over such a long time period and find no occurrence of cervical cancer. Many previous studies have shown that HPV vaccines are extremely effective in preventing cervical cancer. Read the rest…

Vaccines 364

Vaccines 364

Pharmacy Joe

OCTOBER 27, 2021

In this episode, I’ll discuss why I think the journal Intensive Care Medicine is of high quality. While the study was informative, its publication tells us a great deal about the integrity of the Intensive Care Medicine journal, its editorial system, and the researchers involved.

Inpatient 40

Inpatient 40

STAT

APRIL 18, 2024

Wojcicki currently holds 49.99% of the voting power in the company, according to the Wall Street Journal, which first reported on the plan. Wojcicki disclosed her plans in a filing with the Securities and Exchange Commission late Wednesday, saying that she intends to seek out potential partners and financiers to help.

327

327

STAT

MAY 13, 2024

The full results, presented Monday at a heart failure conference of the European Society of Cardiology and published in the New England Journal of Medicine , affirm positive topline results announced last December.

283

283

STAT

APRIL 14, 2024

Several of my Johns Hopkins colleagues and I published a study in the Journal of the American Medical Association showing that some nonprofit hospitals sue and garnish the wages of low-income patients who can’t afford to pay their medical bills.

Hospitals 364

Hospitals 364